4.23
4.23 (0%)
As of Feb 14, 2025
Voyager Therapeutics, Inc. [VYGR]
Source:
Company Overview
Voyager Therapeutics, Inc. is a biotechnology company whose mission is to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases.
| Country | United States |
| Headquarters | lexington, massachusetts |
| Phone Number | (857) 259-5340 |
| Industry | manufacturing |
| CEO | Alfred Sandrock, M.D., Ph.D. |
| Website | www.voyagertherapeutics.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $80 |
| Operating Profit | $-83.3 |
| Net Income | $-65 |
| Net Cash | $3.8 |
Profit Ratios
| Gross Margin | $80 |
| Operating Margin | -104.1 |
| Profit as % of Revenues | -123.1% |
| Profit as % of Assets | -17.5% |
| Profit as % of Stockholder Equity | -21.7% |
Management Effectiveness
| Return on Equity | -21.7% |
| Return on Assets | -16.5% |
| Turnover Ratio | 21.5% |
| EBITA | $-83.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $393.1 |
| Total Liabilities | $93.3 |
| Operating Cash Flow | $-15.3 |
| Investing Cash Flow | $-94.9 |
| Financing Cash Flow | $114 |
